M. Visini
Impact in
- Gastroenterology top 10%
- Gastrointestinal Tumor Research and Treatment
-
- Gastric Cancer Management and Outcomes
- Metastasis and carcinoma case studies
Papers in
- Oncology 4
- Cancer Treatment and Pharmacology 2
- Lung Cancer Research Studies 2
-
- Lung Cancer Diagnosis and Treatment 1
- Lung Cancer Treatments and Mutations 1
- Co-authors
- Maria Di Bartolomeo (2 shared papers)Emilio Bajetta (2 shared papers)Roberto Buzzoni (1 shared paper)Federico Bozzetti (1 shared paper)G. Schieppati (1 shared paper)G. Pinotti (2 shared papers)Elena Beretta (1 shared paper)Giovanni Pietro Ianniello (1 shared paper)
- Journals
- Annals of Oncology (2 papers)Lung (1 paper)Blood Coagulation & Fibrinolysis (1 paper)Oncology (1 paper)Cancer Research (1 paper)
- Partner nations
- ItalySwitzerland
In The Last Decade
M. Visini
7 papers receiving 198 citations
Peers
Comparison fields: 5 of 31
- Gastroenterology 57
- Pulmonary and Respiratory Medicine 124
- Oncology 93
- Neurology 43
- Epidemiology 59
Countries citing papers authored by M. Visini
This map shows the geographic impact of M. Visini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Visini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Visini more than expected).
Fields of papers citing papers by M. Visini
This network shows the impact of papers produced by M. Visini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Visini. The network helps show where M. Visini may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Visini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 105 | |
| 2 | 1995 | 69 | |
| 3 | 2004 | 18 | |
| 4 | 2004 | 5 | |
| 5 | 2008 | 3 | |
| 6 | 2015 | 3 | |
| 7 | 5-year results of cisplatin-epirubicin-vinorelbine (PEV) combination as primary chemotherapy in T2-3, N0-2 breast cancer patients: a multicentre phase II study. | 2007 | 1 |
About M. Visini
M. Visini is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Pathology and Forensic Medicine, having authored 7 papers that have together received 204 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (2 papers), Breast Cancer Treatment Studies (2 papers), Lung Cancer Research Studies (2 papers), Neuroblastoma Research and Treatments (1 paper), Lung Cancer Diagnosis and Treatment (1 paper), Lung Cancer Treatments and Mutations (1 paper), Central Venous Catheters and Hemodialysis (1 paper) and Menopause: Health Impacts and Treatments (1 paper). The work is most often cited by research in Gastroenterology (57 citations), Pulmonary and Respiratory Medicine (124 citations), Oncology (93 citations), Neurology (43 citations) and Epidemiology (59 citations). M. Visini has collaborated with scholars based in Italy and Switzerland. Frequent co-authors include Maria Di Bartolomeo, Emilio Bajetta, Roberto Buzzoni, Federico Bozzetti, G. Schieppati, G. Pinotti, Elena Beretta, Giovanni Pietro Ianniello, Enrico Aitini and S. Fava. Their work appears in journals such as Annals of Oncology, Lung, Blood Coagulation & Fibrinolysis, Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.